-+ 0.00%
-+ 0.00%
-+ 0.00%

NKGEN BIOTECH INC -ON SEPT 23, GOT DEFICIENCY LETTER FROM NASDAQ ON CO'S FAILURE TO SATISFY A CONTINUED LISTING RULE OR STANDARD

Reuters·09/27/2024 20:03:31
Listen to the news
NKGEN BIOTECH INC -ON SEPT 23, GOT DEFICIENCY LETTER FROM NASDAQ ON CO'S FAILURE TO SATISFY A CONTINUED LISTING RULE OR STANDARD